TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea · Delayed Price · Currency is KRW 2,070.00
-100.00 (-4.61%)
Aug 25, 2026, 9:39 AM KST
TELCON RF PHARMACEUTICAL. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 14,868 | 62,827 | 70,587 | 97,672 | 110,233 | 255,964 | |
Market Cap Growth | -77.46% | -10.99% | -27.73% | -11.39% | -56.93% | -50.53% |
Enterprise Value | 24,164 | 56,803 | 107,353 | 107,951 | 136,288 | 323,257 |
Last Close Price | 2170.00 | 9170.00 | 15824.58 | 23534.68 | 27362.78 | 78853.32 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 7.02 | - | - |
PS Ratio | 0.35 | 1.46 | 1.86 | 2.69 | 3.96 | 6.76 |
PB Ratio | 0.15 | 0.58 | 0.85 | 0.93 | 1.31 | 2.40 |
P/TBV Ratio | 0.18 | 0.68 | 1.10 | 1.18 | 1.83 | 3.35 |
P/FCF Ratio | 36.74 | 46.65 | - | - | - | - |
P/OCF Ratio | 16.00 | 37.70 | 57.91 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.56 | 1.32 | 2.84 | 2.97 | 4.90 | 8.54 |
EV/EBITDA Ratio | 3.92 | 10.25 | 24.20 | 20.72 | 623.83 | - |
EV/EBIT Ratio | 19.09 | 79.05 | - | 111.83 | - | - |
EV/FCF Ratio | 59.71 | 42.18 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.41 | 0.32 | 0.67 | 0.26 | 0.36 | 0.53 |
Debt / EBITDA Ratio | 7.00 | 6.18 | 12.55 | 5.26 | 138.58 | - |
Debt / FCF Ratio | 98.40 | 25.45 | - | - | - | - |
Net Debt / Equity Ratio | 0.09 | 0.02 | 0.55 | 0.16 | 0.24 | 0.31 |
Net Debt / EBITDA Ratio | 1.58 | 0.39 | 10.29 | 3.25 | 94.03 | -90.18 |
Net Debt / FCF Ratio | 22.19 | 1.59 | -12.18 | -3.41 | -7.05 | -12.53 |
Asset Turnover | 0.30 | 0.28 | 0.26 | 0.28 | 0.19 | 0.21 |
Inventory Turnover | 6.41 | 6.56 | 5.55 | 5.57 | 4.99 | 6.71 |
Quick Ratio | 0.79 | 0.89 | 0.27 | 0.56 | 0.47 | 0.55 |
Current Ratio | 1.24 | 1.25 | 0.37 | 0.95 | 0.67 | 0.62 |
Return on Equity (ROE) | -10.00% | -11.91% | -28.18% | 14.75% | -44.16% | -23.10% |
Return on Assets (ROA) | 0.34% | 0.29% | -0.03% | 0.46% | -1.77% | -1.62% |
Return on Invested Capital (ROIC) | 0.73% | 0.60% | -0.06% | 0.85% | -3.33% | -3.10% |
Return on Capital Employed (ROCE) | 0.80% | 0.70% | -0.10% | 0.90% | -4.80% | -4.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -55.81% | -18.23% | -37.29% | 14.24% | -38.18% | -9.02% |
FCF Yield | 2.72% | 2.14% | -5.31% | -5.07% | -2.64% | -1.02% |
Buyback Yield / Dilution | -56.76% | -35.21% | 20.93% | -8.89% | -56.33% | -2.65% |